Gastric Gastroesophageal Junction Adenocarcinoma
📧 Sign up to get email alerts when something new happens for Gastric Gastroesophageal Junction Adenocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-03-20Clinical Trial Update: Study of IBI343 in Subjects With Advanced Gastric/Gastroesophageal Junction Adenocarcinoma [Phase 2]
Phase 2 clinical trial update for IBI343 in advanced gastric/gastroesophageal junction adenocarcinoma (no current status).
-
CLINICAL_TRIALS trial_result · 2024-01-26Clinical Trial Update: Comparing Modified XELOX Plus Sintilimab With Standard XELOX Plus Sintilimab in First-line Treatment for HER2-negative Gastric/Gastroesophageal Junction Adenocarcinoma [Phase 3]
Phase 3 clinical trial comparing modified XELOX plus sintilimab versus standard XELOX plus sintilimab as first-line therapy for HER2-negativ…
-
CLINICAL_TRIALS trial_result · 2023-09-11Clinical Trial Update: Study of The Second-line Treatment of Advanced Gastric / Gastroesophageal Junction Adenocarcinoma With Envafolimab and Lenvatinib Combined With Paclitaxel-albumin [Phase 2]
Phase 2 trial update on a second-line treatment combining Envafolimab, Lenvatinib, and Paclitaxel-albumin for advanced gastric/gastroesophag…
-
CLINICAL_TRIALS trial_result · 2022-05-24Clinical Trial Update: Preoperative Short Course Radiotherapy With Envafolimab, Endostatin and SOX Regimen in Locally Advanced Gastric [Phase 2]
Phase 2 trial evaluating preoperative short-course radiotherapy combined with Envafolimab, Endostatin, and the SOX regimen for locally advan…